文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

使用补充氧疗方案抑制早产儿视网膜病变进展

Use of a Supplemental Oxygen Protocol to Suppress Progression of Retinopathy of Prematurity.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

该回顾性队列研究比较了氧疗方案实施前后早产儿视网膜病变(ROP)的进展情况。方案实施前(2002-2007年)44%(54/122)的婴儿病变进展超过2期,实施后(2008-2012年)降至23%(24/103)(P=0.001)。校正出生体重和坏死性小肠结肠炎后,2期ROP婴儿进展超过2期的比值比为0.37(95%CI 0.20-0.67;P=0.0013)。

要点

  • 氧疗方案实施后,ROP进展超过2期的比例从44%(54/122)降至23%(24/103)(P=0.001)。
  • 2期ROP婴儿中,方案实施后进展超过2期的比值比为0.37(95%CI 0.20-0.67;P=0.0013)。
  • 方案实施前后婴儿的胎龄、出生体重、存活率、败血症、支气管肺发育不良等无显著差异。

核心结论

  • 实施氧疗方案后,早产儿从2期进展至3期ROP显著减少,且未伴随肺部疾病发病率的相应增加。
  • 作者认为适当的氧疗可能对抑制2期ROP进展起作用,有可能降低这一脆弱人群终身视力丧失的风险。

研究设计与样本

  • 回顾性队列研究,比较氧疗方案实施前(队列A,2002-2007年)和实施后(队列B,2008-2012年)接受ROP筛查的早产儿。
  • 方案内容为对2期ROP或更严重者采用氧疗以抑制进一步进展。
  • 统计分析采用χ2检验、Fisher精确检验或Wilcoxon秩和检验,并建立logistic回归模型校正其他ROP危险因素。

主要发现

  • 队列A中44%(54/122)的婴儿ROP进展超过2期,队列B中为23%(24/103)(P=0.001)。
  • 队列A与队列B在胎龄、出生体重、存活率、败血症、支气管肺发育不良、出院时用氧或需用利尿剂方面无显著差异。
  • 校正出生体重和坏死性小肠结肠炎差异后,队列B中2期ROP婴儿进展超过2期的比值比为0.37(95%CI 0.20-0.67;P=0.0013)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare progression of retinopathy of prematurity (ROP) before and after institution of an oxygen therapy protocol to inhibit active proliferation and progression of ROP in premature infants. METHODS: A retrospective cohort study was performed of premature infants undergoing ROP screening before (cohort A) and after (cohort B) implementation of an oxygen therapy protocol to inhibit further progression for those with stage 2 ROP or worse. Statistical analysis with χ2, Fisher's exact test, or Wilcoxon rank sum test was performed; and logistic regression models were created to determine the odds ratio of cohort B developing ROP progression beyond stage 2, compared to cohort A, adjusting for other risk factors for ROP. RESULTS: In cohort A, without oxygen therapy protocol (2002-2007), 44% (54/122) of infants progressed beyond stage 2, compared to 23% (24/103) of infants after protocol implementation (cohort B, 2008-2012) (P = 0.001). No significant differences between cohort A and B were found for gestational age, birth weight, survival, sepsis, bronchopulmonary dysplasia, oxygen at discharge, or need for diuretics. Infants with stage 2 ROP in cohort B, with oxygen therapy protocol, had significantly decreased risk of ROP beyond stage 2 (odds ratio 0.37, 95% confidence interval 0.20-0.67; P = 0.0013), compared to cohort A, correcting for differences in birth weight and necrotizing enterocolitis. CONCLUSIONS: Progression from stage 2 to stage 3 ROP in premature infants was significantly decreased after implementation of an oxygen therapy protocol, without a corresponding increase in pulmonary morbidity. This study suggests that appropriate oxygen therapy may play a role in inhibiting progression of stage 2 ROP, potentially decreasing the risk of lifelong visual loss in this vulnerable population.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Colaizy TT, Longmuir S, Gertsch K, et al. Use of a Supplemental Oxygen Protocol to Suppress Progression of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2017. PMID: 28159975. doi:10.1167/iovs.16-20822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。